天康生物(002100.SZ)发布上半年业绩，归母净利润3.38亿元，增长22.27%

Core Viewpoint - TianKang Biological (002100.SZ) reported a revenue of 8.847 billion yuan for the first half of 2025, reflecting a year-on-year growth of 10.68% [1] - The net profit attributable to shareholders of the listed company was 338 million yuan, representing a year-on-year increase of 22.27% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 314 million yuan, showing a year-on-year growth of 16.17% [1] - The basic earnings per share stood at 0.25 yuan [1]